Animal Blood Plasma and Derivatives Market - Outlook and Forecast 2021-2027

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Animal Blood Plasma and Derivatives Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Animal Blood Plasma and Derivatives Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Animal Blood Plasma and Derivatives Overall Market Size
2.1 Global Animal Blood Plasma and Derivatives Market Size: 2021 VS 2027
2.2 Global Animal Blood Plasma and Derivatives Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Animal Blood Plasma and Derivatives Players in Global Market
3.2 Top Global Animal Blood Plasma and Derivatives Companies Ranked by Revenue
3.3 Global Animal Blood Plasma and Derivatives Revenue by Companies
3.4 Top 3 and Top 5 Animal Blood Plasma and Derivatives Companies in Global Market, by Revenue in 2020
3.5 Global Companies Animal Blood Plasma and Derivatives Product Type
3.6 Tier 1, Tier 2 and Tier 3 Animal Blood Plasma and Derivatives Players in Global Market
3.6.1 List of Global Tier 1 Animal Blood Plasma and Derivatives Companies
3.6.2 List of Global Tier 2 and Tier 3 Animal Blood Plasma and Derivatives Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Animal Blood Plasma and Derivatives Market Size Markets, 2021 & 2027
4.1.2 Immunoglobulin
4.1.3 Fibrinogen
4.1.4 Serum Albumin
4.1.5 Fetal Bovine Serum
4.1.6 Thrombin
4.1.7 New Born Calf Serum
4.2 By Type - Global Animal Blood Plasma and Derivatives Revenue & Forecasts
4.2.1 By Type - Global Animal Blood Plasma and Derivatives Revenue, 2016-2021
4.2.2 By Type - Global Animal Blood Plasma and Derivatives Revenue, 2022-2027
4.2.3 By Type - Global Animal Blood Plasma and Derivatives Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Animal Blood Plasma and Derivatives Market Size, 2021 & 2027
5.1.2 Food & Beverages
5.1.3 Pharmaceuticals
5.1.4 Cosmetics
5.1.5 Feed
5.1.6 Others
5.2 By Application - Global Animal Blood Plasma and Derivatives Revenue & Forecasts
5.2.1 By Application - Global Animal Blood Plasma and Derivatives Revenue, 2016-2021
5.2.2 By Application - Global Animal Blood Plasma and Derivatives Revenue, 2022-2027
5.2.3 By Application - Global Animal Blood Plasma and Derivatives Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Animal Blood Plasma and Derivatives Market Size, 2021 & 2027
6.2 By Region - Global Animal Blood Plasma and Derivatives Revenue & Forecasts
6.2.1 By Region - Global Animal Blood Plasma and Derivatives Revenue, 2016-2021
6.2.2 By Region - Global Animal Blood Plasma and Derivatives Revenue, 2022-2027
6.2.3 By Region - Global Animal Blood Plasma and Derivatives Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Animal Blood Plasma and Derivatives Revenue, 2016-2027
6.3.2 US Animal Blood Plasma and Derivatives Market Size, 2016-2027
6.3.3 Canada Animal Blood Plasma and Derivatives Market Size, 2016-2027
6.3.4 Mexico Animal Blood Plasma and Derivatives Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Animal Blood Plasma and Derivatives Revenue, 2016-2027
6.4.2 Germany Animal Blood Plasma and Derivatives Market Size, 2016-2027
6.4.3 France Animal Blood Plasma and Derivatives Market Size, 2016-2027
6.4.4 U.K. Animal Blood Plasma and Derivatives Market Size, 2016-2027
6.4.5 Italy Animal Blood Plasma and Derivatives Market Size, 2016-2027
6.4.6 Russia Animal Blood Plasma and Derivatives Market Size, 2016-2027
6.4.7 Nordic Countries Animal Blood Plasma and Derivatives Market Size, 2016-2027
6.4.8 Benelux Animal Blood Plasma and Derivatives Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Animal Blood Plasma and Derivatives Revenue, 2016-2027
6.5.2 China Animal Blood Plasma and Derivatives Market Size, 2016-2027
6.5.3 Japan Animal Blood Plasma and Derivatives Market Size, 2016-2027
6.5.4 South Korea Animal Blood Plasma and Derivatives Market Size, 2016-2027
6.5.5 Southeast Asia Animal Blood Plasma and Derivatives Market Size, 2016-2027
6.5.6 India Animal Blood Plasma and Derivatives Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Animal Blood Plasma and Derivatives Revenue, 2016-2027
6.6.2 Brazil Animal Blood Plasma and Derivatives Market Size, 2016-2027
6.6.3 Argentina Animal Blood Plasma and Derivatives Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Animal Blood Plasma and Derivatives Revenue, 2016-2027
6.7.2 Turkey Animal Blood Plasma and Derivatives Market Size, 2016-2027
6.7.3 Israel Animal Blood Plasma and Derivatives Market Size, 2016-2027
6.7.4 Saudi Arabia Animal Blood Plasma and Derivatives Market Size, 2016-2027
6.7.5 UAE Animal Blood Plasma and Derivatives Market Size, 2016-2027
7 Players Profiles
7.1 Proliant Inc.
7.1.1 Proliant Inc. Corporate Summary
7.1.2 Proliant Inc. Business Overview
7.1.3 Proliant Inc. Animal Blood Plasma and Derivatives Major Product Offerings
7.1.4 Proliant Inc. Animal Blood Plasma and Derivatives Revenue in Global (2016-2021)
7.1.5 Proliant Inc. Key News
7.2 Thermo Fisher Scientific, Inc.
7.2.1 Thermo Fisher Scientific, Inc. Corporate Summary
7.2.2 Thermo Fisher Scientific, Inc. Business Overview
7.2.3 Thermo Fisher Scientific, Inc. Animal Blood Plasma and Derivatives Major Product Offerings
7.2.4 Thermo Fisher Scientific, Inc. Animal Blood Plasma and Derivatives Revenue in Global (2016-2021)
7.2.5 Thermo Fisher Scientific, Inc. Key News
7.3 Merck KGaA
7.3.1 Merck KGaA Corporate Summary
7.3.2 Merck KGaA Business Overview
7.3.3 Merck KGaA Animal Blood Plasma and Derivatives Major Product Offerings
7.3.4 Merck KGaA Animal Blood Plasma and Derivatives Revenue in Global (2016-2021)
7.3.5 Merck KGaA Key News
7.4 Kraeber & Co GmbH
7.4.1 Kraeber & Co GmbH Corporate Summary
7.4.2 Kraeber & Co GmbH Business Overview
7.4.3 Kraeber & Co GmbH Animal Blood Plasma and Derivatives Major Product Offerings
7.4.4 Kraeber & Co GmbH Animal Blood Plasma and Derivatives Revenue in Global (2016-2021)
7.4.5 Kraeber & Co GmbH Key News
7.5 LAMPIRE Biological Laboratories, Inc.
7.5.1 LAMPIRE Biological Laboratories, Inc. Corporate Summary
7.5.2 LAMPIRE Biological Laboratories, Inc. Business Overview
7.5.3 LAMPIRE Biological Laboratories, Inc. Animal Blood Plasma and Derivatives Major Product Offerings
7.5.4 LAMPIRE Biological Laboratories, Inc. Animal Blood Plasma and Derivatives Revenue in Global (2016-2021)
7.5.5 LAMPIRE Biological Laboratories, Inc. Key News
7.6 Lake Immunogenics, Inc.
7.6.1 Lake Immunogenics, Inc. Corporate Summary
7.6.2 Lake Immunogenics, Inc. Business Overview
7.6.3 Lake Immunogenics, Inc. Animal Blood Plasma and Derivatives Major Product Offerings
7.6.4 Lake Immunogenics, Inc. Animal Blood Plasma and Derivatives Revenue in Global (2016-2021)
7.6.5 Lake Immunogenics, Inc. Key News
7.7 Rocky Mountain Biologicals Inc.
7.7.1 Rocky Mountain Biologicals Inc. Corporate Summary
7.7.2 Rocky Mountain Biologicals Inc. Business Overview
7.7.3 Rocky Mountain Biologicals Inc. Animal Blood Plasma and Derivatives Major Product Offerings
7.4.4 Rocky Mountain Biologicals Inc. Animal Blood Plasma and Derivatives Revenue in Global (2016-2021)
7.7.5 Rocky Mountain Biologicals Inc. Key News
7.8 ANZCO Foods Ltd.
7.8.1 ANZCO Foods Ltd. Corporate Summary
7.8.2 ANZCO Foods Ltd. Business Overview
7.8.3 ANZCO Foods Ltd. Animal Blood Plasma and Derivatives Major Product Offerings
7.8.4 ANZCO Foods Ltd. Animal Blood Plasma and Derivatives Revenue in Global (2016-2021)
7.8.5 ANZCO Foods Ltd. Key News
7.9 Auckland BioSciences Ltd.
7.9.1 Auckland BioSciences Ltd. Corporate Summary
7.9.2 Auckland BioSciences Ltd. Business Overview
7.9.3 Auckland BioSciences Ltd. Animal Blood Plasma and Derivatives Major Product Offerings
7.9.4 Auckland BioSciences Ltd. Animal Blood Plasma and Derivatives Revenue in Global (2016-2021)
7.9.5 Auckland BioSciences Ltd. Key News
7.10 Bovogen Biologicals Pty Ltd.
7.10.1 Bovogen Biologicals Pty Ltd. Corporate Summary
7.10.2 Bovogen Biologicals Pty Ltd. Business Overview
7.10.3 Bovogen Biologicals Pty Ltd. Animal Blood Plasma and Derivatives Major Product Offerings
7.10.4 Bovogen Biologicals Pty Ltd. Animal Blood Plasma and Derivatives Revenue in Global (2016-2021)
7.10.5 Bovogen Biologicals Pty Ltd. Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer


List of Tables
Table 1. Animal Blood Plasma and Derivatives Market Opportunities & Trends in Global Market
Table 2. Animal Blood Plasma and Derivatives Market Drivers in Global Market
Table 3. Animal Blood Plasma and Derivatives Market Restraints in Global Market
Table 4. Key Players of Animal Blood Plasma and Derivatives in Global Market
Table 5. Top Animal Blood Plasma and Derivatives Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Animal Blood Plasma and Derivatives Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Animal Blood Plasma and Derivatives Revenue Share by Companies, 2016-2021
Table 8. Global Companies Animal Blood Plasma and Derivatives Product Type
Table 9. List of Global Tier 1 Animal Blood Plasma and Derivatives Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Animal Blood Plasma and Derivatives Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type

Proliant Inc.
Thermo Fisher Scientific, Inc.
Merck KGaA
Kraeber & Co GmbH
LAMPIRE Biological Laboratories, Inc.
Lake Immunogenics, Inc.
Rocky Mountain Biologicals Inc.
ANZCO Foods Ltd.
Auckland BioSciences Ltd.
Bovogen Biologicals Pty Ltd.